A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time

por Wilson, Brooke E., Desnoyers, Alexandra, Al-Showbaki, Laith, Nadler, Michelle B., Amir, Eitan
Publicado 2022

Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies

por Al-Showbaki, Laith, Almugbel, Fahad A, Alqaisi, Husam A, Amir, Eitan, Chen, Eric X
Publicado 2022

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

por Al-Showbaki, Laith, Nadler, Michelle B., Desnoyers, Alexandra, Almugbel, Fahad A., Cescon, David W., Amir, Eitan
Publicado 2021

Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review

por Al-Showbaki, Laith, Wilson, Brooke, Tamimi, Faris, Molto, Consolacion, Mittal, Abhenil, Cescon, David W, Amir, Eitan
Publicado 2023

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

por Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Di Iorio, Massimo, Al-Showbaki, Laith, Cescon, David W, Amir, Eitan
Publicado 2023